Sources | Names Used |
---|---|
CTRPv2 | doxorubicin:navitoclax (2:1 mol/mol) |
PharmacoGx | doxorubicin:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TOP3A | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
mRNA | RP11-345J4.5 | CTRPv2 | pan-cancer | AAC | -0.14 | 1e-05 |
mRNA | PLEC | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
mRNA | RCBTB1 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
mRNA | MTURN | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
mRNA | DHX8 | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
mRNA | BLZF1 | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
mRNA | TMEM208 | CTRPv2 | pan-cancer | AAC | -0.14 | 1e-05 |
mRNA | TMED7-TICAM2 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
mRNA | SRSF10 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |